Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Study Group: Ritalin Prescribers(?)

Council Members in this Study Group: 29

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Request a survey with this Study Group







Leading Experts in this Study Group

Amit Vijapura, MD, Owner, Amit Vijapura, MDAmit Vijapura, MD
Owner
Amit Vijapura, MD

Amit Vijapura, MD, is a Private Practitioner in Psychiatry based in Florida. He has over 15 years of experience in the field and has expertise in depression, bipolar disorder, anxiety disorder, attention deficient disorder, and schizophrenia. Dr. Vijapura is board certified in Psychiatry and is also...

Rami Kaminski, MD
Founder and Director
Institute for Integrative Psychiatry

Rami Kaminski, MD, is Director and Founder of the Institute for Integrative Psychiatry in New York, a not-for-profit organization aimed at evaluating current psychiatric services and how they integrate with medicine, such as the mutual effects between medical and psychiatric conditions. Prior to that,...

GLG NewsSMAnalyses by this Study Group's Leading Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Will Strattera be around in 3 years? | 05-12-2008
Author: GLG Expert Contributor

My personal prediction is that this product will NOT be on the market in 3-5 years.  My clinical experience never approached that which the research would suggest.  I suspect that the "research" that was done on this product is frought with company incentives.

Current trends with Venture Capital Funds and IPO's | 04-08-2008
Analysis of: Venture Activity Hit by U.S. Slowdown | online.wsj.com
Author: GLG Expert Contributor

As a partner @ a VC fund I  see this trend impacting how potential portfolio companies are evaluated.  Companies that will have a future acquisition, as an liquidity event, will have a higher probability of being funded.  Investment decisons are also being influenced by the potential...

Results of phase 1 trial, on treatment of parkinson's disease, presented @ scientific forum | 12-19-2007
Author: GLG Expert Contributor

This is a very significant event for Ceregene.  Previous studies, with drug treatment, on treatment for parkinsons have shown that the placebo effect only lasts for three months.  The symptoms of Parkinson's  increase 5-10% per year( as part of the natural progression of the disorder). ...

Lilly has great product pipe line for Schizophrenia and other Psychiatric Disorders | 09-24-2007
Author: Amit Vijapura, MD, Owner, Amit Vijapura, MD

Lilly is currently leader in Psychiatry with 4 active medications with great marketing for Psychiatry and Primary care physician. New compound that has a unique mechanism on Metabotropic Glutamate 2/3 Receptors, can work on Schizophrenia and other Psychiatric diagnosis. This is great opportunity...

wanning immunity as a future public health issue | 08-09-2007
Analysis of: Hepatitis B Vaccine Protection May Not Be Long-Lasting | www.medpagetoday.com
Author: GLG Expert Contributor

I have long been concerned about this issue - not only for Hep B, but moreover for Varicella, and measles, etc.  It is my prediction that, before the end of my medical career, immunizations will take a greater part in the Family Medicine/Internal Medicine practices, and people will need to receive...

View All GLG News by members of this Study Group

Most Common Company Types:

  • Academic Medical Center/Hospital or Clinic
  • Office Based Private Practice or Clinic
  • Other Freestanding Healthcare Facility
  • Government/Military Hospital or Clinic
  • Private/For-Profit Healthcare Research Entity
  • Academic Institution*
  • Non-Academic Community Hospital or Clinic
  • Non-profit organization
  • Venture Capital

Most Common Job Types:

  • Physician - Attending Physician
  • Owner
  • Physician - Director
  • Director
  • President
  • Physician - Division Head
  • Professor

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics


Generated at 2008-12-05T01:45:24.617